Table 1.
Subject characteristics
| Controls (n = 27) | Patients (n = 24) | Difference | |
|---|---|---|---|
| Age in years (M, SD) | 59.37 (8.54) | 63.42 (7.93) | ns |
| Education level (M, SD) | 6.15 (0.86) | 5.25 (1.11) | U = 174.5, p = 0.003 |
| Gender | 11 females | 7 females | ns |
| Disease duration in years (M, SD) | – | 4.08 (3.13) | – |
| LEDD in mg (M, SD) | – | 796.29 (616.44) | – |
| UPDRS during ON phase (M, SD) | – | 17.67 (7.66) | – |
| MoCA (M, SD) | 27.89 (1.89) | 26.88 (1.92) | ns |
| BDI | 22.96 (2.24) | 30.46 (7.12) | U = 82.5, p < 0.001 |
LEDD Levodopa equivalent daily dose, UPDRS United Parkinson’s disease rating scale, MoCA montreal cognitive assessment, BDI Beck’s depression inventory